Financial results for Q3 ended September 30, 2023
Sanofi-Aventis Pharmaceutical Pakistan Limited (SAPL) · View SAPL share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from Sanofi-Aventis Pharmaceutical Pakistan Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 5831380
- Unconsolidated Pat
- 469498
- Unconsolidated Quarter Eps
- 48.68
- Unconsolidated Cumulative Eps
- -5.48